AT403422T
Substituted hydrazones as inhibitors of cyclooxygenase-2
Abstract
The compound defined by the formula I or the formula Ia useful as inhibitor of cyclooxygenase *2 activity is offered. In addition, Fig. 2 compares the growth inhibition activity of the compound 4* ブロモ benzaldehyde *4* スルファ mill phenylhydrazone of the case of the operation 4, and celecoxib to human colon rectum tumor cell line HT29.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
42 members in 10 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 33892701 | United States of America | P |
Members42
| Document | Office | Kind | |
|---|---|---|---|
| US2003077025A1 | United States of America | A1 | |
| US2003077031A1 | United States of America | A1 | |
| WO03036350A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO03036355A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US2003107798A1 | United States of America | A1 | |
| US2003108275A1 | United States of America | A1 | |
| US2003108289A1 | United States of America | A1 | |
| US2003108290A1 | United States of America | A1 | |
| CA2469709A1 | Canada | A1 | |
| WO03049698A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002351331A1 | Australia | A1 | |
| US2003123798A1 | United States of America | A1 | |
| US2003128918A1 | United States of America | A1 | |
| US6608715B2 | United States of America | B2 | |
| WO03049698A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2003179998A1 | United States of America | A1 | |
| US6628858B2 | United States of America | B2 | |
| US2003187035A1 | United States of America | A1 | |
| US2003198259A1 | United States of America | A1 | |
| US6683711B2 | United States of America | B2 | |
| WO2004010186A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2003263772A1 | Australia | A1 | |
| TW200405050A | Taiwan Province of China | A | |
| EP1438619A1 | European Patent Office (EPO) | A1 | |
| US2004146240A1 | United States of America | A1 | |
| TWI220179B | Taiwan Province of China | B | |
| WO03049698A8 | World Intellectual Property Organization (WIPO) | A8 | |
| EP1476149A2 | European Patent Office (EPO) | A2 | |
| US6842563B2 | United States of America | B2 | |
| US6879754B2 | United States of America | B2 | |
| US6891989B2 | United States of America | B2 | |
| JP2005513046A | Japan | A | |
| EP1476149A4 | European Patent Office (EPO) | A4 | |
| TWI242658B | Taiwan Province of China | B | |
| US6973231B2 | United States of America | B2 | |
| EP1438619A4 | European Patent Office (EPO) | A4 | |
| US7003190B2 | United States of America | B2 | |
| CN1751254A | China | A | |
| US7122571B2 | United States of America | B2 | |
| EP1476149B1 | European Patent Office (EPO) | B1 | |
| AT403422TThis record | Austria | T | |
| DE60228134D1 | Germany | D1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 2786980
Titles2
- German
- SUBSTITUIERTE HYDRAZONE ALS HEMMER VON CYCLOOXYGENASE-2
- English
- SUBSTITUTED HYDRAZONE AS AN INHIBITOR OF CYCLOOXYGENASE-2
Classification
- CPC, 13
- C07D209/14
- A61K31/18
- A61K31/40
- A61K31/44
- A61K31/63
- A61P9/00
- C07C311/39
- A61P9/10
- C07C311/49
- A61P25/28
- A61P29/00
- A61P35/00
- A61P43/00
- IPC, 27
- A61K31 18
- A61K31 341
- A61K31 381
- A61K31 40
- A61K31 4045
- A61K31 44
- A61K31 63
- A61P25 28
- A61P29 00
- A61P35 00
- A61P43 00
- A61P9 00
- A61P9 10
- C07C303 40
- C07C311 37
- C07C311 39
- C07C311 49
- C07D209 14
- C07D307 52
- C07D333 22
- G02B6 12
- G02B6 124
- G02B6 125
- G02B6 28
- G02B6 34
- G02B6 35
- H04Q11 00